ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX)
| Fund Assets | 175.55M |
| Expense Ratio | 1.56% |
| Min. Investment | $15,000 |
| Turnover | 52.00% |
| Dividend (ttm) | 0.25 |
| Dividend Yield | 0.34% |
| Dividend Growth | -98.13% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 30, 2025 |
| Previous Close | 73.49 |
| YTD Return | 9.20% |
| 1-Year Return | 93.49% |
| 5-Year Return | 6.76% |
| 52-Week Low | 34.47 |
| 52-Week High | 80.00 |
| Beta (5Y) | n/a |
| Holdings | 160 |
| Inception Date | Jun 19, 2000 |
About BIPIX
The ProFunds Biotechnology UltraSector Fund Investor Class is a leveraged mutual fund focused on the biotechnology sector of the U.S. equity market. Its primary objective is to achieve daily investment results that correspond to 1.5 times the daily performance of the S&P Biotechnology Select Industry Index. This index measures the performance of biotechnology companies within the S&P Total Market Index. The fund employs financial instruments and derivatives to amplify its exposure to biotechnology stocks, making it a non-diversified fund with a portfolio that typically includes around 146 holdings. Founded in 2000, the fund targets growth and value stocks across various market capitalizations within healthcare, pharmaceuticals, biotech, and life sciences industries. It serves as a specialized investment vehicle designed to provide leveraged exposure to the biotechnology sector, catering to investors seeking amplified returns linked to the daily movements of biotechnology equities. The fund’s expense ratio stands at approximately 1.56%, and it distributes dividends semi-annually. Its role in the financial markets lies in catering to active traders and investors who want leveraged sector exposure within biotechnology.
Performance
BIPIX had a total return of 93.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.21%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| BIPSX | Service Class | 2.56% |
Top 10 Holdings
186.73% of assets| Name | Symbol | Weight |
|---|---|---|
| Asset Offset | n/a | 80.64% |
| Bipix_spsibi_ub | n/a | 38.71% |
| Bipix_spsibi_goldman | n/a | 36.68% |
| Societe' Generale 3.55 , 2/02/2026 | n/a | 7.86% |
| Natwest Markets Plc 3.53 , 2/02/2026 | n/a | 6.29% |
| Hsbc Securities (Usa), Inc. 3.55 , 2/02/2026 | n/a | 6.05% |
| Royal Bank Of Canada 3.45 , 2/02/2026 | n/a | 3.39% |
| Umb Financial Corp. B 3.4 , 2/02/2026 | n/a | 3.37% |
| Short-Term Investment Trust - Invesco Government & Agency Portfolio | AGPXX | 2.34% |
| Moderna, Inc. | MRNA | 1.40% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.22675 | Dec 31, 2025 |
| Dec 19, 2025 | $0.01967 | Dec 22, 2025 |
| Dec 31, 2024 | $0.10468 | Jan 2, 2025 |
| Dec 27, 2024 | $13.04498 | Dec 30, 2024 |
| Dec 20, 2023 | $4.12801 | Dec 21, 2023 |
| Dec 21, 2020 | $8.0736 | Dec 21, 2020 |